Viking Therapeutics, Inc insider trading
VKTXfinancial statementsForm 4 filings on EDGAR64 transactions since Nov 16, 2024
From August 19, 2026 to November 16, 2026, 0 insiders at Viking Therapeutics, Inc bought $0 of stock in the open market, and 0 sold $0. Officers and directors accounted for $0 of purchases and $0 of sales. The last reported transaction was an award by Kelly-Gemmell Dorothy Elizabeth on August 1, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through August 7, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $0Aug 19, 2026 – Nov 16, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Nov 13, 2026. Insider data through Nov 16, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
64 transactions from November 16, 2024 to November 16, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2026 | Kelly-Gemmell Dorothy Elizabeth | Director | award | 6,333 | $0.00 | — | 6,333 | Aug 7, 2026 |
| Jul 29, 2026 | Lian Brian | President & CEO, Director | open-market sale | 148,517 | $33.32 | $5M | 3M | Jul 29, 2026 |
| Jul 29, 2026 | Zante Greg | Chief Financial Officer | open-market sale | 21,217 | $33.47 | $710K | 212,204 | Jul 29, 2026 |
| Jul 29, 2026 | Mancini Marianna | Chief Operating Officer | open-market sale | 18,217 | $33.47 | $610K | 422,760 | Jul 29, 2026 |
| Jul 28, 2026 | Lian Brian | President & CEO, Director | award | 221,667 | $0.00 | — | 3M | Jul 29, 2026 |
| Jul 28, 2026 | Zante Greg | Chief Financial Officer | award | 31,667 | $0.00 | — | 233,421 | Jul 29, 2026 |
| Jul 28, 2026 | Mancini Marianna | Chief Operating Officer | award | 31,667 | $0.00 | — | 440,977 | Jul 29, 2026 |
| Mar 10, 2026 | Aubuchon Neil William | Chief Commercial Officer | open-market buy | 4,475 | $33.50 | $150K | 4,475 | Mar 10, 2026 |
| Jan 5, 2026 | Zante Greg | Chief Financial Officer | open-market sale | 31,961 | $32.30 | $1M | 215,571 | Jan 5, 2026 |
| Jan 5, 2026 | Zante Greg | Chief Financial Officer | open-market sale | 13,900 | $33.38 | $464K | 201,671 | Jan 5, 2026 |
| Jan 5, 2026 | Zante Greg | Chief Financial Officer | open-market sale | 10,300 | $34.24 | $353K | 191,371 | Jan 5, 2026 |
| Jan 5, 2026 | Zante Greg | Chief Financial Officer | open-market sale | 1,500 | $32.09 | $48K | 189,891 | Jan 5, 2026 |
| Jan 5, 2026 | Mancini Marianna | Chief Operating Officer | open-market sale | 31,961 | $32.29 | $1M | 434,890 | Jan 5, 2026 |
| Jan 5, 2026 | Mancini Marianna | Chief Operating Officer | open-market sale | 13,600 | $33.37 | $454K | 421,290 | Jan 5, 2026 |
| Jan 5, 2026 | Mancini Marianna | Chief Operating Officer | open-market sale | 10,500 | $34.22 | $359K | 410,790 | Jan 5, 2026 |
| Jan 5, 2026 | Mancini Marianna | Chief Operating Officer | open-market sale | 1,600 | $35.07 | $56K | 409,190 | Jan 5, 2026 |
| Jan 5, 2026 | Lian Brian | President & CEO, Director | open-market sale | 6,400 | $35.07 | $224K | 2M | Jan 5, 2026 |
| Jan 5, 2026 | Lian Brian | President & CEO, Director | open-market sale | 53,279 | $33.38 | $2M | 3M | Jan 5, 2026 |
| Jan 5, 2026 | Lian Brian | President & CEO, Director | open-market sale | 41,276 | $34.22 | $1M | 3M | Jan 5, 2026 |
| Jan 5, 2026 | Lian Brian | President & CEO, Director | open-market sale | 132,454 | $32.29 | $4M | 3M | Jan 5, 2026 |
| Jan 2, 2026 | Zante Greg | Chief Financial Officer | award | 41,000 | $0.00 | — | 215,483 | Jan 5, 2026 |
| Jan 2, 2026 | Zante Greg | Chief Financial Officer | award | 32,049 | $0.00 | — | 247,532 | Jan 5, 2026 |
| Jan 2, 2026 | Mancini Marianna | Chief Operating Officer | award | 41,000 | $0.00 | — | 434,802 | Jan 5, 2026 |
| Jan 2, 2026 | Mancini Marianna | Chief Operating Officer | award | 32,049 | $0.00 | — | 466,851 | Jan 5, 2026 |
| Jan 2, 2026 | Lian Brian | President & CEO, Director | award | 224,080 | $0.00 | — | 3M | Jan 5, 2026 |
| Jan 2, 2026 | Lian Brian | President & CEO, Director | award | 78,400 | $0.00 | — | 3M | Jan 5, 2026 |
| Jan 2, 2026 | Singleton J Matthew | Director | award | 3,150 | $0.00 | — | 12,650 | Jan 5, 2026 |
| Jan 2, 2026 | Macartney Lawson | Director | award | 3,150 | $0.00 | — | 51,115 | Jan 5, 2026 |
| Jan 2, 2026 | Rowland Charles A Jr | Director | award | 3,150 | $0.00 | — | 33,150 | Jan 5, 2026 |
| Jan 2, 2026 | Foehr Matthew W | Director | award | 3,150 | $0.00 | — | 135,186 | Jan 5, 2026 |
| Jan 2, 2026 | Foehr Matthew W | Director | option exercise | 16,000 | $3.33 | $53K | 148,036 | Jan 5, 2026 |
| Jan 2, 2026 | Foehr Matthew W | Director | open-market sale | 16,000 | $35.11 | $562K | 132,036 | Jan 5, 2026 |
| Jan 2, 2026 | Rouan Sarah Kathryn | Director | award | 3,150 | $0.00 | — | 4,390 | Jan 5, 2026 |
| Oct 28, 2025 | Mancini Marianna | Chief Operating Officer | open-market sale | 6,185 | $35.00 | $216K | 382,467 | Oct 28, 2025 |
| Oct 28, 2025 | Lian Brian | President & CEO, Director | open-market sale | 38,989 | $35.01 | $1M | 2M | Oct 28, 2025 |
| Oct 28, 2025 | Zante Greg | Chief Financial Officer | open-market sale | 6,185 | $35.00 | $216K | 173,592 | Oct 28, 2025 |
| Oct 27, 2025 | Mancini Marianna | Chief Operating Officer | award | 11,117 | $0.00 | — | 388,652 | Oct 28, 2025 |
| Oct 27, 2025 | Rowland Charles A Jr | Director | open-market sale | 60,000 | $35.57 | $2M | 30,000 | Oct 28, 2025 |
| Oct 27, 2025 | Rowland Charles A Jr | Director | award | 22,000 | $4.88 | $107K | 90,000 | Oct 28, 2025 |
| Oct 27, 2025 | Rowland Charles A Jr | Director | award | 22,000 | $5.80 | $128K | 68,000 | Oct 28, 2025 |
| Oct 27, 2025 | Rowland Charles A Jr | Director | award | 16,000 | $4.48 | $72K | 46,000 | Oct 28, 2025 |
| Oct 27, 2025 | Lian Brian | President & CEO, Director | award | 70,084 | $0.00 | — | 2M | Oct 28, 2025 |
| Oct 27, 2025 | Zante Greg | Chief Financial Officer | award | 11,117 | $0.00 | — | 179,777 | Oct 28, 2025 |
| Jul 3, 2025 | Lian Brian | President & CEO, Director | open-market sale | 26,889 | $27.80 | $748K | 2M | Jul 3, 2025 |
| Jul 3, 2025 | Zante Greg | Chief Financial Officer | open-market sale | 4,266 | $27.76 | $118K | 168,660 | Jul 3, 2025 |
| Jul 3, 2025 | Mancini Marianna | Chief Operating Officer | open-market sale | 4,266 | $27.77 | $118K | 377,535 | Jul 3, 2025 |
| Jul 2, 2025 | Lian Brian | President & CEO, Director | award | 48,333 | $0.00 | — | 2M | Jul 3, 2025 |
| Jul 2, 2025 | Zante Greg | Chief Financial Officer | award | 7,667 | $0.00 | — | 172,926 | Jul 3, 2025 |
| Jul 2, 2025 | Mancini Marianna | Chief Operating Officer | award | 7,667 | $0.00 | — | 381,801 | Jul 3, 2025 |
| Apr 11, 2025 | Foehr Matthew W | Director | option exercise | 20,786 | $8.00 | $166K | 132,036 | Apr 14, 2025 |
Who the insiders are
Everyone who reported a transaction since November 16, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Lian Brian | President & CEO, Director | Jul 29, 2026 | open-market sale | 3M | — | $13M (5) | 0 of 5 |
| Zante Greg | Chief Financial Officer | Jul 29, 2026 | open-market sale | 212,204 | — | $3M (5) | 0 of 5 |
| Mancini Marianna | Chief Operating Officer | Jul 29, 2026 | open-market sale | 422,760 | — | $3M (5) | 0 of 5 |
| Foehr Matthew W | Director | Jan 2, 2026 | award | 135,186 | — | $562K (1) | 0 of 1 |
| Aubuchon Neil William | Chief Commercial Officer | Mar 10, 2026 | open-market buy | 4,475 | $150K (1) | — | — |
| Rowland Charles A Jr | Director | Jan 2, 2026 | award | 33,150 | — | — | — |
| Rouan Sarah Kathryn | Director | Jan 2, 2026 | award | 4,390 | — | — | — |
| Kelly-Gemmell Dorothy Elizabeth | Director | Aug 1, 2026 | award | 6,333 | — | — | — |
| Singleton J Matthew | Director | Jan 2, 2026 | award | 12,650 | — | — | — |
| Macartney Lawson | Director | Jan 2, 2026 | award | 51,115 | — | — | — |
Questions
Are Viking Therapeutics, Inc insiders buying or selling?
Over the twelve months to November 16, 2026, 4 insiders at Viking Therapeutics, Inc sold $18M of stock in the open market, all by officers and directors, and 1 insider bought $150K, all by officers and directors. Net, insiders sold $18M. Only open-market purchases and sales are counted.
Who sold the most Viking Therapeutics, Inc stock in the last year?
Lian Brian (President & CEO, Director) sold $13M in 5 open-market sales over the twelve months to November 16, 2026.
Do Viking Therapeutics, Inc executives sell under 10b5-1 plans?
0 of the 16 open-market sales in the last twelve months (0%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Viking Therapeutics, Inc
- Viking Therapeutics, Inc financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.